Vasoactive intestinal polypeptide has been demonstrated to lack inherent ef
fects on capillary permeability, but also to potentiate the oedema promotin
g actions of other inflammatory mediators or even to strongly reduce organ
damage and subsequent oedema in ischemic models of the lung and heart. This
study investigated the role of VIP on oedema in partial- and full-thicknes
s skin burns of anaesthetised rats in vivo by spectrophotometrical quantifi
cation of Evans blue albumin. Results show that systemic VIP elicited a sig
nificant drop in mean arterial blood pressure versus saline (p < 0.001) and
VIP antiserum (p < 0.001) both in burned and non-burned animals. VIP also
decreased heart rate versus saline (p < 0.05) and anti-VIP (p;< 0.01) in no
n-burned and burned animals. EB-albumin in normal skin was significantly in
hibited by VIP as compared to saline (p < 0.05), but did not differ signifi
cantly from VIP-antiserum. A significant inhibition of EB-albumin extravasa
tion versus saline was also seen following administration of VIP-antiserum
(p < 0.01). Similarly, VIP significantly reduced EB-albumin extravasation v
ersus saline treatment in partial-thickness (p < 0.01) and full-thickness b
urns (p < 0.001), while VIP-antiserum had no significant effect on skin per
fusion in any of the burned groups as compared to saline treatment. The pre
sent results show that systemic VIP is a potent inhibitor of burn oedema. T
his effect could be secondary to constriction of skin vessels as a result o
f VIP-induced systemic hypotension or be mediated by the interaction of VIP
with other oedema promoting mediators released following a thermal trauma
to the skin. (C) 2000 Elsevier Science Ltd and ISBI. All rights reserved.